FDA currently allows the use, on a case-by-case basis, of an
investigational drug outside of a clinical trial to treat a patient with a
serious or immediately life-threatening disease or condition who has no
comparable or satisfactory alternative treatment options. However, FDA often
denies this access.
HR 4475, the
Compassionate Freedom of Choice Act of 2014, has been officially introduced
by Rep. Morgan Griffith. The bill eliminates the requirement for an FDA okay, and
streamlines physician and patient access to experimental drugs. It would ensure
that dying patients and their families—who don’t have the time or the strength
to do so—won’t have to wage fruitless bureaucratic wars.
The bill is currently in the House Energy and Commerce
Committee. Please ask your representative to support HR 4475!
Please personalize your message, if you have the time!
Dear [Decision Maker],
Sincerely,[Your Name] [Your Address] [City, State ZIP]